Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaci.2012.02.051 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs.
Inflamm Intest Dis
July 2024
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Article Synopsis
- Eosinophilic esophagitis (EoE) is a chronic condition driven by food allergies that causes changes in the esophagus, necessitating treatment options like medications, dietary changes, and dilation.
- Recently approved treatments include oral budesonide tablets (Jorveza) in Europe, Canada, and Australia, and an orodispersible budesonide suspension (Eohilia) in the USA, both shown to effectively induce and maintain remission in EoE patients.
- Other treatment considerations include off-label proton-pump inhibitors, which have inconsistent results, and Dupilumab, a monoclonal antibody approved for EoE treatment in multiple regions, available for older adolescents and adults who don't respond to
Efficacy and safety profile of doxofylline in asthma: a meta-analysis.
J Asthma
September 2024
Pediatrics, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
Article Synopsis
- The research investigates the effectiveness and safety of doxofylline in treating asthma, analyzing studies published until March 2023.
- A total of eight clinical trials involving 1627 patients showed no significant improvement in lung function metrics (like FEV1 and FVC) between doxofylline and control groups, but doxofylline was linked to reduced adverse reactions and fewer asthma events.
- The study concludes that doxofylline has a good safety profile and offers longer-term benefits in asthma management compared to certain other treatments.
Clinical efficacy of montelukast sodium combination therapy for cough variant asthma in children: A meta-analysis.
Pediatr Pulmonol
June 2024
Pediatric Area II, The Second Affiliated Hospital of Hainan Medical College, Haikou, Hainan, China.
This meta-analysis aims to assess the clinical effectiveness of combination therapy with montelukast sodium for the treatment of cough variant asthma (CVA) in children, intending to provide clinical evidence and data to guide the selection of clinical therapy. A literature review was conducted using numerous databases, including China National Knowledge Infrastructure (CNKI), Wanfang database, Embase, PubMed, and Web of Science, from inception to December 2023. Trials meeting the criteria for the combined treatment of montelukast sodium for CVA in children were included.
View Article and Find Full Text PDFPharmacological interventions for pediatric obstructive sleep apnea (OSA): Network meta-analysis.
Sleep Med
April 2024
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) Ministry of Education, Chengdu, China. Electronic address:
Importance: Pediatric obstructive sleep apnea (OSA) is a common disease that can have significant negative impacts on a child's health and development. A comprehensive evaluation of different pharmacologic interventions for the treatment of OSA in children is still lacking.
Objective: This study aims to conduct a comprehensive systematic review and network meta-analysis of pharmacological interventions for the management of obstructive sleep apnea in pediatric population.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!